Cancer antigen-125 and risk of atrial fibrillation: a systematic review and meta-analysis
Angel Cheung(Brown University), Gary Tse(Observational & Pragmatic Research Institute), Sunny H. Wong(Nanyang Technological University), Gregory Y.H. Lip(Medical University of Białystok), Julio Núñez(Centro de Investigación Biomédica en Red), Sadeq Ali‐Hasan‐Al‐Saegh(Shahid Sadoughi University of Medical Sciences and Health Services), Thomas D. Stamos(University of Illinois Chicago), William Ka Kei Wu(Quantitative BioSciences), Eulàlia Roig(Hospital de Sant Pau), George Bazoukis(Evangelismos Hospital), Martin C. S. Wong(Chinese University of Hong Kong), Roberto Bellanti(Oxford University Hospitals NHS Trust), Κωνσταντίνος Λαμπρόπουλος(Evangelismos Hospital), Adrián Baranchuk(Population Health Research Institute), Tong Liu(Second Hospital of Tianjin Medical University), Kaya Hakki(Sivas Cumhuriyet Üniversitesi), Mehmet Birhan Yılmaz(Istanbul University-Cerrahpaşa), Guangping Li(Qingdao University), Mengqi Gong(Central South University), Lap Ah Tse(Chinese University of Hong Kong), Wing Tak Wong(Chinese University of Hong Kong), Jichao Zhao(University of Auckland)
Cited by 23
Related Papers
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
|European Heart Journal|2016|2.5k
2016 ESC Position Paper on Cancer Treatments and Cardiovascular Toxicity Developed Under the Auspices of the ESC Committee for Practice Guidelines
|European Journal of Heart Failure|2016|1.8k